AGING PPAR AND HEPATIC PEROXISOMES
AGING PPAR AND HEPATIC PEROXISOMES
批准号:
2012369
负责人:
MOSTAFA Zaki BADR
金额:
$9.96万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-08-15 至 2000-08-14
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted from applicant's abstract and specific aims): Several
isoforms of the peroxisome proliferator-activated receptor (PPAR) have
recently been discovered and implicated in the process of peroxisome
proliferation. It is reported that while PPAR-alpha (PPAR-a) is responsible
for the pleiotropic effects of peroxisome proliferators, PPAR-delta (PPAR-d)
and PPAR-d may play a repressive role in this process. Tissues which are
most responsive to peroxisome proliferators express high amount of PPAR-a
and low amounts of the other two isoforms. Studies also show that
fenofibrate, a peroxisome proliferator, enhanced the expression of hepatic
PPAR-a. Preliminary data show a decline in basal and inducible levels of
hepatic peroxisomal enzymes in aged animals. The investigators hypothesize
that aged animals have lower levels of PPAR-a and/or higher levels of PPAR-a
and PPAR-d, compared to young animals, and the expression of PPAR-a is not
enhanced in livers of aged rats by peroxisome proliferators, to levels
observed in young animals. The investigators will test this hypothesis by:
(1) quantitating hepatic constitutive levels of the various PPAR isoforms in
young (4,10 wk), mature (20 wk) and aged (50,100 wk). (2) determining the
level of inducibility of PPAR-a in response to several structurally
dissimilar peroxisome proliferators (WY-14,643, DEHP, clofibrate, PFOA) in
these animals groups, (3) correlating levels of individual PPAR isoforms
with peroxisomal enzyme activities in livers of various age group rats
untreated and treated with peroxisome proliferators. The purpose of these
experiments will be to investigate the relationship between levels of
expression of the various PPAR isoforms and constitutive levels of
peroxisomal enzyme activities as well as the extent of the pleiotropic
response to peroxisome proliferators in the livers of young and aged
animals. Recent published findings showing that inhibiting peroxisomal
enzyme activities shortened the animal longevity and the fact that aged
animals have reduced peroxisomal activities, necessitates an urgent
evaluation of the possibly that the decline in these activities may
contribute to the process of aging.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Age-dependent effects of nongenotoxic hepatocarcinogens on liver apoptosis in vivo.
非基因毒性肝癌物质对体内肝细胞凋亡的年龄依赖性影响。
DOI:
10.1016/s0047-6374(02)00189-6
发表时间:
2003
期刊:
Mechanisms of ageing and development
影响因子:
5.3
作者:
[Youssef,JihanA, Bouziane,Mohammed, Badr,MostafaZ]
通讯作者:
Badr,MostafaZ
Diminished energy metabolism and enhanced apoptosis in livers of B6C3F1 mice treated with the antihepatocarcinogen rotenone.
用抗肝癌药物鱼藤酮治疗的 B6C3F1 小鼠肝脏中能量代谢减少,细胞凋亡增强。
DOI:
10.1023/a:1007024905046
发表时间:
1999
期刊:
Molecular and cellular biochemistry
影响因子:
4.3
作者:
[Wang,C, Youssef,J, Saran,B, Rothberg,PG, Cunningham,ML, Molteni,A, Badr,M]
通讯作者:
Badr,M
Biology of senescent liver peroxisomes: role in hepatocellular aging and disease.
衰老肝过氧化物酶体的生物学:在肝细胞衰老和疾病中的作用。
DOI:
10.1289/ehp.99107791
发表时间:
1999
期刊:
Environmental health perspectives
影响因子:
10.4
作者:
[Youssef,J, Badr,M]
通讯作者:
Badr,M
BRAIN OXIDATIVE STRESS--A SIGN OF AGING OR EMINENT DEATH
-
批准号:6195289
-
项目类别:
-
资助金额:$7.25万
-
财政年份:2000
-
负责人:MOSTAFA Zaki BADR
-
依托单位:
ALTERED LIPID METABOLISM IN PEROXISOMAL PROLIFERATION
-
批准号:3438148
-
项目类别:
-
资助金额:$7.08万
-
财政年份:1988
-
负责人:MOSTAFA Zaki BADR
-
依托单位:
国内基金
海外基金
木薯CC类谷氧还蛋白MeGRXC3修饰Catalase1蛋白调控过氧化氢酶活性的分子机制
-
批准号:32360458
-
项目类别:地区科学基金项目
-
资助金额:32.00万元
-
批准年份:2023
-
负责人:郭鑫
-
依托单位:
Catalase调控滑膜巨噬细胞NLRP3炎症小体/Caspase-1/IL-1β轴修复骨关节炎软骨损伤的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2019
-
负责人:李斯明
-
依托单位: